Profile data is unavailable for this security.
About the company
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The Company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and others.
- Revenue in INR (TTM)825.63m
- Net income in INR100.94m
- Incorporated1998
- Employees74.00
- LocationQuest Laboratories LtdPlot No. 45 Sector Iii PithampurDHAR 454775IndiaIND
- Phone+91 7 312882168
- Websitehttps://www.questlabltd.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sotac Pharmaceuticals Ltd | 579.83m | 44.96m | 1.66bn | 89.00 | 26.88 | 10.48 | 27.08 | 2.86 | 5.58 | 5.58 | 60.69 | 14.31 | -- | -- | -- | -- | -- | -- | -- | -- | 30.90 | -- | 7.75 | -- | 0.9968 | 8.62 | 0.4806 | -- | -20.74 | -- | 56.17 | -- | -- | -- |
| Bafna Pharmaceuticals Ltd | 1.44bn | 2.73m | 1.82bn | 618.00 | 665.00 | -- | 33.15 | 1.27 | 0.1159 | 0.1159 | 60.96 | -- | -- | -- | -- | 2,326,939.00 | -- | 5.45 | -- | 8.23 | 26.69 | 35.05 | 0.19 | 5.97 | -- | 0.3419 | -- | -- | 32.15 | 28.45 | -35.19 | -- | 116.51 | -- |
| Aarey Drugs and Pharmaceuticals Ltd | 4.72bn | 65.28m | 1.89bn | 0.00 | 26.84 | -- | 22.82 | 0.4004 | 2.51 | 2.51 | 179.80 | -- | -- | -- | -- | -- | -- | 2.30 | -- | 5.01 | 2.99 | 3.58 | 1.38 | 1.40 | -- | 0.5731 | -- | -- | -5.57 | 2.21 | 24.20 | -6.46 | -10.07 | -- |
| Krebs Biochemicals And Industries Ltd | 527.29m | -195.67m | 1.91bn | 191.00 | -- | -- | -- | 3.63 | -9.08 | -9.08 | 24.47 | -- | -- | -- | -- | 2,760,691.00 | -- | -17.87 | -- | -27.01 | 85.82 | 15.68 | -37.11 | -58.62 | -- | -3.08 | -- | -- | -3.29 | 1.09 | 20.10 | -- | 16.76 | -- |
| Quest Laboratories Ltd | 825.63m | 100.94m | 1.97bn | 74.00 | 17.99 | 5.02 | 18.51 | 2.39 | 6.69 | 6.69 | 58.30 | 23.99 | -- | -- | -- | 11,157,140.00 | -- | -- | -- | -- | 36.72 | -- | 12.23 | -- | 0.8904 | 33.56 | 0.1507 | -- | 33.94 | -- | 100.73 | -- | -- | -- |
| Bal Pharma Ltd | 3.43bn | 75.67m | 2.01bn | -- | 26.50 | -- | 11.45 | 0.5863 | 4.81 | 4.81 | 217.63 | -- | -- | -- | -- | -- | -- | 0.5654 | -- | 1.57 | 44.05 | 43.04 | 2.22 | 0.5638 | -- | 1.36 | -- | 79.39 | 11.51 | 8.56 | 187.44 | 14.31 | 5.02 | 3.71 |
| Mangalam Drugs and Organics Ltd | 3.58bn | 31.71m | 2.04bn | 432.00 | 64.48 | -- | 11.18 | 0.5708 | 2.00 | 2.00 | 225.39 | -- | -- | -- | -- | 8,279,234.00 | -- | 3.28 | -- | 5.89 | 38.76 | 27.83 | 0.8866 | 2.59 | -- | 0.9785 | -- | -- | -0.9827 | 10.12 | -812.51 | -- | 13.92 | -- |
| Zenith Drugs Ltd | -100.00bn | -100.00bn | 2.17bn | -- | -- | 9.57 | -- | -- | -- | -- | -- | 13.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8679 | -- | 0.5617 | -- | 24.95 | -- | 64.70 | -- | -- | -- |
| Vaishali Pharma Ltd | 909.37m | 8.32m | 2.35bn | -- | 469.30 | -- | 175.62 | 2.59 | 0.4111 | 0.4111 | 80.14 | -- | -- | -- | -- | -- | -- | 3.21 | -- | 7.50 | 13.14 | 16.14 | 0.9149 | 3.59 | -- | 0.3948 | -- | -- | 23.85 | 2.82 | -89.11 | 0.1492 | -17.83 | -- |
